Juan J. Sancho

Juan J. Sancho

Auto-generated profile, based on publicly available information

Juan J. Sancho

Department of Surgery, Hospital del Mar, Barcelona, Spain

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 July 2008 in British Journal of Surgery
Verified
Journal Article
Closed access
PDF file
JSJ J Sancho
J J Sancho
MPM Pascual-Damieta
M Pascual-Damieta
JPJ A Pereira
J A Pereira
MCM J Carrera
M J Carrera
JFJ Fontané
J Fontané
ASA Sitges-Serra
A Sitges-Serra

16 December 2011 in Langenbeck's Archives of Surgery
Verified
Journal Article
Closed access
JSJuan J. Sancho
Juan J. Sancho
FTFrédéric Triponez
Frédéric Triponez
XMXavier Montet
Xavier Montet
ASAntonio Sitges-Serra
Antonio Sitges-Serra

1 July 1992 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
JSJ. J. Sancho
J. J. Sancho
JRJ. Rouco
J. Rouco
RRR. Riera‐Vidal
R. Riera‐Vidal
ASA. Sitges‐Serra
A. Sitges‐Serra

23 August 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
NCNatalia Cornellà
Natalia Cornellà
JSJoan Sancho
Joan Sancho
ASAntonio Sitges-Serra
Antonio Sitges-Serra
Long-term all-cause mortality and dependency after complex surgical procedures have not been assessed in the framework of value-based medicine. The aim of this study was to investigate the postoperative and long-term outcomes after surgical procedures lasting for more than six hours. Retrospective cohort study of patients undergoing a first elective complex surgical procedure between 2004 and 2013. Heart and transplant surgery was excluded. Mortality and dependency from the healthcare system were selected as outcome variables. Gender, age, ASA, creatinine, albumin kinetics, complications, benign vs malignant underlying condition, number of drugs at discharge, and admission and length of stay in the ICU were recorded as predictive variables. Some 620 adult patients were included in the study. Postoperative, <1year and <5years cumulative mortality was 6.8%, 17.6% and 45%, respectively. Of patients discharged from hospital after surgery, 76% remained dependent on the healthcare system. In multivariate analysis for postoperative, <1year and 7days, were the most significant independent predictive variables. Prolonged surgery carries a significant short and long-term mortality and disability. These data may contribute to more informed decisions taken concerning major surgery in the framework of value-based medicine.

14 July 2010 in Langenbeck's Archives of Surgery
Verified
Journal Article
Closed access
PDF file
JGJoaquín Gómez-Ramírez
Joaquín Gómez-Ramírez
JSJuan Jose Sancho-Insenser
Juan Jose Sancho-Insenser
JPJose Antonio Pereira
Jose Antonio Pereira
JJJaime Jimeno
Jaime Jimeno
AMAssumpta Munné
Assumpta Munné
ASAntonio Sitges-Serra
Antonio Sitges-Serra

1 December 2017 in Gland Surgery
Verified
Journal Article
Closed access
PDF file
LLLeyre Lorente-Poch
Leyre Lorente-Poch
JSJuan J. Sancho
Juan J. Sancho
LCLeticia Carballo
Leticia Carballo
ASAntonio Sitges-Serra
Antonio Sitges-Serra
Background: Parathyroid failure is the most common complication after total thyroidectomy but permanent impairment of the parathyroid function is unusual. Limited data is available assessing long-term follow-up, quality of life and complications occurring in patients with permanent hypoparathyroidism (PH). We aimed to assess the incidence of complications derived from PH status, their influence on the quality of life perceived by PH patients and its relation to standard medical treatment with calcium salts and active vitamin D analogues. Methods: Cross-sectional observational study of consecutive patients undergoing total thyroidectomy who developed PH and were followed at least twice a year at a referral endocrine surgery unit. PH was defined as intact parathyroid hormone (iPTH) levels <13 pg/mL and the need for replacement therapy with calcium and/or vitamin D for at least 1 year after surgery. Quality of life was assessed using the SF-36 questionnaire. Data regarding doses and type of vitamin D analogues and calcium supplementation, serum calcium fluctuations, bone densitometry and renal ultrasound were recorded. Results: The cohort included 32 patients (3 male/29 female) with a mean age of 51.2±15.2 years. The mean follow-up was 78±68 months and the total follow-up length was 70,080 PH patient/days. Five (15.6%) patients showed a decreased renal function. At least one clinical adverse event was observed in 18 (56.3%) patients. There was a slight decrease of the punctuation in the SF-36 questionnaire for the perceived quality of life that was only significant for the emotional role. Conclusions: PH and its treatment carry a mild to moderate burden of illness if followed closely. During a mean follow-up of nearly 6 years, only half of the patients suffered a relevant clinical event with little impact on their quality of life.